Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TPTE2 pseudogene 1 (TPTE2P1) is a genomic sequence highly homologous to the TPTE2 protein-coding gene. Unlike TPTE2, which is a membrane-associated lipid phosphatase active in the metabolism of inositol phospholipids and is involved in signal transduction (and potentially tumor suppression)[1][2], TPTE2P1 does not produce a functional protein. As with other pseudogenes, TPTE2P1 may exert biological effects at the RNA level, such as acting as a competitive endogenous RNA (ceRNA) that sponges microRNAs or modulates the stability of related transcripts[3][4]. While pseudogenes like PTENP1 are known to influence disease by regulating their parental gene, there is currently no specific evidence for TPTE2P1 being clinically actionable or recognized as a therapeutic target. Its molecular classification is therefore as a "pseudogene" and it does not fit commonly targeted categories such as enzyme or receptor. If searching for a drug target, focus should be placed on the TPTE2 gene (Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2), not its pseudogene TPTE2P1[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TPTE2 pseudogene 1 (TPTE2P1).